Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Low DHEA-S reflects reduced adrenal androgen output and HPA axis drive.

Low circulating DHEA-S indicates diminished adrenal androgen synthesis and commonly reflects reduced hypothalamic–pituitary–adrenal (ACTH) drive.

PlausibleJune 19, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

DHEA-S is produced primarily by the adrenal cortex under ACTH control, so low DHEA-S commonly reflects reduced adrenal androgen output that can occur alongside reduced overall HPA axis drive.

laying out figure…
2 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

DHEA-S is generated in the adrenal cortex via ACTH-stimulated steroidogenic signaling that upregulates enzymes converting DHEA into its sulfated reservoir, so circulating levels track adrenal androgen production. Consequently, suppressed DHEA-S levels serve as a stable clinical marker of reduced adrenal androgen output and often parallel reduced central HPA axis drive, though age-related adrenopause or stress-driven shifts in steroidogenesis can confound interpretation.

Verified conclusion

Dehydroepiandrosterone sulfate (DHEA-S) is a major circulating steroid hormone produced almost exclusively by the adrenal cortex, serving as a principal marker of adrenal androgenic activity. Because its synthesis relies on central signaling, circulating levels of DHEA-S are highly reflective of overall hypothalamic-pituitary-adrenal (HPA) axis drive.

Mechanistic pathways of androgen synthesis

  • ACTH-mediated signaling: Adrenocorticotropic hormone (ACTH) binds directly to the melanocortin 2 receptor (MC2R) on cells within the adrenal zona reticularis, initiating a cyclic AMP (cAMP) and protein kinase A (PKA) signaling cascade.
  • Enzymatic activation: This intracellular pathway upregulates key steroidogenic components, including steroidogenic acute regulatory (StAR) protein, cytochrome P450 17A1 (CYP17A1) exhibiting 17,20-lyase activity, and sulfotransferase 2A1 (SULT2A1), which converts dehydroepiandrosterone (DHEA) into its highly stable sulfated reservoir, DHEA-S.

Clinical evidence and diagnostic context

  • Marker of HPA hypofunction: Because of its long biological half-life, low DHEA-S serves as a reliable clinical surrogate for reduced adrenal androgen output. In conditions like secondary adrenal insufficiency, a lack of pituitary ACTH drive causes a parallel drop in both cortisol and DHEA-S.
  • Confounding factors: In a 51-year-old female, low DHEA-S must be carefully differentiated from adrenopause—a natural, age-related decline in adrenal androgens that occurs independently of cortisol or ACTH changes. Furthermore, chronic stress can pathologically shift steroidogenesis toward cortisol production, skewing the cortisol-to-DHEA-S ratio.

Bottom line

  • Key takeaway: Suppressed DHEA-S levels reliably reflect diminished adrenal androgen output, which often occurs alongside reduced HPA axis drive; however, clinicians must differentiate true HPA axis hypofunction from age-related adrenopause or stress-induced steroidogenic shifting by co-evaluating morning cortisol and ACTH levels.

References

  1. Adrenal changes associated with adrenarche — pmc.ncbi.nlm.nih.gov ↗
  2. A New Model for Adrenarche: Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 2 by Intra-Adrenal Cortisol — pmc.ncbi.nlm.nih.gov ↗
  3. The Immunoregulatory Actions of DHEA in Tuberculosis, A Tool for Therapeutic Intervention? — frontiersin.org ↗
  4. Molecular Mechanisms of Stem/Progenitor Cell Maintenance in the Adrenal Cortex — pmc.ncbi.nlm.nih.gov ↗
  5. Serum dehydroepiandrosterone sulfate in assessing the integrity of the hypothalamic-pituitary-adrenal axis — pmc.ncbi.nlm.nih.gov ↗
  6. MON-025 Diagnostic Utility Of Machine Learning In Central Adrenal Insufficiency Due To Pituitary Disorders — academic.oup.com ↗
  7. Dehydroepiandrosterone sulfate (DHEA-S), cortisol, and adrenocorticotropic hormone (ACTH) levels in drug-naïve, first-episode patients with psychosis. — psychiatriki-journal.gr ↗
  8. Measurements of serum DHEA and DHEA sulphate levels improve the accuracy of the low-dose cosyntropin test in the diagnosis of central adrenal insufficiency. — pmc.ncbi.nlm.nih.gov ↗
  9. Exploring The Diagnostic Association Between Cortisol And DHEA-S Concentrations In Patients Experiencing Chronic Depressive Disorders — directivepublications.org ↗
  10. Diurnal patterns and associations among salivary cortisol, DHEA and alpha-amylase in older adults — pmc.ncbi.nlm.nih.gov ↗
  11. Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis. — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→